3-bromopyruvate

3-bromopyruvate
Trade Name
Orphan Indication Bile duct cancer
USA Market Approval USA
USA Designation Date 2013-03-05 00:00:00
Sponsor Primocure Pharma, Inc.;1732 1st Avenue, #23222;New York, New York, 10128